← Browse by Condition
Medical Condition
anxiety disorders
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2
Anxiety disorder trials span generalized anxiety disorder (GAD), social anxiety disorder, PTSD, OCD, and panic disorder, with increasing interest in neurobiological targets beyond serotonin and GABA systems. PTSD research has been particularly active following MDMA-assisted therapy trials showing striking efficacy in Phase 3 studies.
Trials evaluate CRHR1 antagonists, V1b antagonists, cannabidiol formulations, MDMA-assisted psychotherapy, exposure-based digital therapeutics, and transcranial magnetic stimulation. PTSD trials often recruit veterans and first responders through VA and DoD partnerships.
Frequently Asked Questions — anxiety disorders Clinical Trials
How many clinical trials are currently recruiting for anxiety disorders?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for anxiety disorders, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for anxiety disorders?
anxiety disorders research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a anxiety disorders clinical trial?
Eligibility criteria for anxiety disorders trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT00018057 Phase 2
Recruiting
Enrollment
3,500 pts
Location
United States
Sponsor
National Institute of Mental H...
NCT07576686
Recruiting
Enrollment
120 pts
Location
Serbia
Sponsor
Aleksandra Stojanovic
NCT00397111
Recruiting
Enrollment
390 pts
Location
United States
Sponsor
National Institute of Mental H...
NCT05712057
Recruiting
Enrollment
240 pts
Location
United States
Sponsor
Duke University
NCT05863520
Recruiting
Enrollment
200 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT05419934
Recruiting
Enrollment
60 pts
Location
France
Sponsor
Fondation Lenval
Related Conditions
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology